In a report released yesterday, Vik Chopra from Wells Fargo assigned a Buy rating to Masimo (MASI – Research Report), with a price target ...

Activist investor Politan Capital secured two board seats at medical technology company Masimo, ousting founder and CEO Joe Kiani and director Chris Chavez. According to an anonymous source familiar ...

Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS ...

Shares of Masimo (NASDAQ: MASI) are trading nearly 3% higher early on Friday after activist investor Politan Capital Management, owner of a 9% stake in the company, disclosed its ...

Many questions surround Masimo after shareholders elected Politan Capital Management's nominees to the board, ousting founder ...